1. Home
  2. UHS vs CRL Comparison

UHS vs CRL Comparison

Compare UHS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Health Services Inc.

UHS

Universal Health Services Inc.

HOLD

Current Price

$145.22

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$199.75

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UHS
CRL
Founded
1978
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
8.6B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
UHS
CRL
Price
$145.22
$199.75
Analyst Decision
Buy
Buy
Analyst Count
11
12
Target Price
$216.36
$198.27
AVG Volume (30 Days)
1.0M
750.7K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
0.48%
N/A
EPS Growth
37.34
N/A
EPS
5.65
N/A
Revenue
$17,364,829,000.00
$1,857,601,000.00
Revenue This Year
$7.67
N/A
Revenue Next Year
$4.99
$3.04
P/E Ratio
$25.81
N/A
Revenue Growth
9.71
10.48
52 Week Low
$140.08
$144.26
52 Week High
$246.33
$228.88

Technical Indicators

Market Signals
Indicator
UHS
CRL
Relative Strength Index (RSI) 41.16 65.64
Support Level $140.08 $193.41
Resistance Level $148.18 $228.64
Average True Range (ATR) 4.06 7.12
MACD 1.03 0.54
Stochastic Oscillator 58.72 83.68

Price Performance

Historical Comparison
UHS
CRL

About UHS Universal Health Services Inc.

Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: